Indapamide (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Indapamide" in Italian language version.

refsWebsite

Global rank Italian rank

32nih.gov

4^th place

9^th place

8doi.org

2^nd place

7^th place

7oadoi.org

799^th place

22^nd place

6archive.org

6^th place

8^th place

1fda.gov

447^th place

644^th place

archive.org

KM. Chow, CC. Szeto; TY. Wong; CB. Leung; PK. Li, Risk factors for thiazide-induced hyponatraemia., in QJM, vol. 96, n. 12, Dic 2003, pp. 911-7, PMID 14631057.
TY. Chan, Indapamide-induced severe hyponatremia and hypokalemia., in Ann Pharmacother, vol. 29, n. 11, Nov 1995, pp. 1124-8, PMID 8573958.
LM. Prisant, SP. Beall; GE. Nichoalds; EB. Feldman; AA. Carr; DS. Feldman; CG. Hames, Biochemical, endocrine, and mineral effects of indapamide in black women., in J Clin Pharmacol, vol. 30, n. 2, Feb 1990, pp. 121-6, PMID 2179276.
SA. Spinler, NJ. Globus; JZ. Raymond; ML. Lancefield, Indapamide-associated Stevens-Johnson syndrome., in Cutis, vol. 50, n. 3, Set 1992, pp. 200-2, PMID 1526175.
P. Blain, M. Paques; P. Massin; A. Erginay; P. Santiago; A. Gaudric, Acute transient myopia induced by indapamide., in Am J Ophthalmol, vol. 129, n. 4, Apr 2000, pp. 538-40, PMID 10764870.
EA. Hasanova, NE. Agasiyeva, Bleeding associated with indapamide SR therapy., in Ann Pharmacother, vol. 39, n. 1, Gen 2005, pp. 199-200, DOI:10.1345/aph.1E323, PMID 15590874.

doi.org

dx.doi.org

NS. Mok, CK. Tong; HC. Yuen, Concomitant-acquired Long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia., in Pacing Clin Electrophysiol, vol. 31, n. 6, Giu 2008, pp. 772-5, DOI:10.1111/j.1540-8159.2008.01085.x, PMID 18507554.
KP. Letsas, IP. Alexanian; LK. Pappas; SP. Kounas; M. Efremidis; A. Sideris; F. Kardaras, QT interval prolongation and torsade de pointes associated with indapamide., in Int J Cardiol, vol. 112, n. 3, Ott 2006, pp. 373-4, DOI:10.1016/j.ijcard.2005.07.055, PMID 16260053.
A. Perciaccante, A. Fiorentini, QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al., in Int J Cardiol, vol. 122, n. 3, Nov 2007, pp. 255; author reply 256-7, DOI:10.1016/j.ijcard.2006.11.245, PMID 17368589.
N. Ohashi, S. Minemura; A. Togawa; K. Ohyama, A case of hypokalemia-induced fatal arrhythmia caused by indapamide in an anorexic elderly patient., in Clin Exp Nephrol, vol. 15, n. 5, Ott 2011, pp. 761-4, DOI:10.1007/s10157-011-0474-5, PMID 21671161.
M. Debono, R. Banerjee, Indapamide-induced hyperparathyroidism: a case report., in Eur J Clin Pharmacol, vol. 63, n. 8, Ago 2007, pp. 809-11, DOI:10.1007/s00228-007-0316-2, PMID 17549466.
D. Bayramgürler, C. Erçin; R. Apaydin; G. Unal, Indapamide-induced pemphigus foliaceus., in J Dermatolog Treat, vol. 12, n. 3, Set 2001, pp. 175-7, DOI:10.1080/09546630152608320, PMID 12243711.
M. Végh, A. Hári-Kovács; K. Réz; B. Tapasztó; A. Szabó; A. Facskó, Indapamide-induced transient myopia with supraciliary effusion: case report., in BMC Ophthalmol, vol. 13, 2013, p. 58, DOI:10.1186/1471-2415-13-58, PMID 24138779.
EA. Hasanova, NE. Agasiyeva, Bleeding associated with indapamide SR therapy., in Ann Pharmacother, vol. 39, n. 1, Gen 2005, pp. 199-200, DOI:10.1345/aph.1E323, PMID 15590874.

fda.gov

Onyeka Otugo, Olabode Ogundare, Christopher Vaughan, Emmanuel Fadiran, Leyla Sahin, Consistency of Pregnancy Labeling Across Different Therapeutic Classes (PDF), su fda.gov, Food and Drug Administration - Office of Women’s Health, 1979. URL consultato l'11 marzo 2014.

nih.gov

ncbi.nlm.nih.gov

CP. Wang, GB. Guo, Indapamide induced syncope in a patient with long QT syndrome., in Pacing Clin Electrophysiol, vol. 25, n. 9, Set 2002, pp. 1397-9, PMID 12380780.
C. Cosma, C. Pauly-Laubry; J. Py, [Electrocardiographic disturbances induced by the simultaneous administration of indapamide and disopyramide]., in Nouv Presse Med, vol. 7, n. 38, Nov 1978, p. 3455, PMID 740527.
NS. Mok, CK. Tong; HC. Yuen, Concomitant-acquired Long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia., in Pacing Clin Electrophysiol, vol. 31, n. 6, Giu 2008, pp. 772-5, DOI:10.1111/j.1540-8159.2008.01085.x, PMID 18507554.
KP. Letsas, IP. Alexanian; LK. Pappas; SP. Kounas; M. Efremidis; A. Sideris; F. Kardaras, QT interval prolongation and torsade de pointes associated with indapamide., in Int J Cardiol, vol. 112, n. 3, Ott 2006, pp. 373-4, DOI:10.1016/j.ijcard.2005.07.055, PMID 16260053.
A. Perciaccante, A. Fiorentini, QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al., in Int J Cardiol, vol. 122, n. 3, Nov 2007, pp. 255; author reply 256-7, DOI:10.1016/j.ijcard.2006.11.245, PMID 17368589.
F. Guzzini, R. Baroffio; D. Coppetti; P. Gasparini, [Severe ventricular arrhythmia secondary to indapamide-induced hypopotassemia]., in Clin Ter, vol. 135, n. 4, Nov 1990, pp. 283-7, PMID 1705875.
N. Ohashi, S. Minemura; A. Togawa; K. Ohyama, A case of hypokalemia-induced fatal arrhythmia caused by indapamide in an anorexic elderly patient., in Clin Exp Nephrol, vol. 15, n. 5, Ott 2011, pp. 761-4, DOI:10.1007/s10157-011-0474-5, PMID 21671161.
M. Debono, R. Banerjee, Indapamide-induced hyperparathyroidism: a case report., in Eur J Clin Pharmacol, vol. 63, n. 8, Ago 2007, pp. 809-11, DOI:10.1007/s00228-007-0316-2, PMID 17549466.
SJ. Read, HM. Trenerry; GF. Whiting, Hyponatraemia and raised creatine kinase level associated with indapamide., in Med J Aust, vol. 161, n. 10, Nov 1994, pp. 607-8, PMID 7968730.
MD. Chapman, R. Hanrahan; J. McEwen; JE. Marley, Hyponatraemia and hypokalaemia due to indapamide., in Med J Aust, vol. 176, n. 5, Mar 2002, pp. 219-21, PMID 11999238.
KM. Chow, CC. Szeto; TY. Wong; CB. Leung; PK. Li, Risk factors for thiazide-induced hyponatraemia., in QJM, vol. 96, n. 12, Dic 2003, pp. 911-7, PMID 14631057.
TY. Yong, JE. Huang; SY. Lau; JY. Li, Severe hyponatremia and other electrolyte disturbances associated with indapamide., in Curr Drug Saf, vol. 6, n. 3, Lug 2011, pp. 134-7, PMID 22122387.
M. Al Qahtani, A. Alshahrani; A. Alskaini; N. Abukhalid; N. Al Johani; M. Al Ammari; L. Al Swaidan; S. Binsalih; A. Al Sayyari; A. Theaby, Prevalence of hyponatremia among patients who used indapamide and hydrochlorothiazide: a single center retrospective study., in Saudi J Kidney Dis Transpl, vol. 24, n. 2, Mar 2013, pp. 281-5, PMID 23538350.
TY. Chan, Indapamide-induced severe hyponatremia and hypokalemia., in Ann Pharmacother, vol. 29, n. 11, Nov 1995, pp. 1124-8, PMID 8573958.
LG. Howes, Hyponatraemia and hypokalaemia caused by indapamide., in Med J Aust, vol. 177, n. 1, Lug 2002, pp. 53-4; author reply 54, PMID 12088485.
Hypokalaemia and hyponatraemia due to indapamide., in Prescrire Int, vol. 11, n. 62, Dic 2002, p. 183, PMID 12472097.
G. Leonetti, A. Rappelli; A. Salvetti; L. Scapellato, Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension., in Am J Cardiol, vol. 65, n. 17, Mag 1990, pp. 67H-71H, PMID 2184655.
LM. Prisant, SP. Beall; GE. Nichoalds; EB. Feldman; AA. Carr; DS. Feldman; CG. Hames, Biochemical, endocrine, and mineral effects of indapamide in black women., in J Clin Pharmacol, vol. 30, n. 2, Feb 1990, pp. 121-6, PMID 2179276.
M. De Barrio, P. Tornero; JM. Zubeldia; Z. Sierra; V. Matheu; T. Herrero, Fixed drug eruption induced by indapamide. Cross-reactivity with sulfonamides., in J Investig Allergol Clin Immunol, vol. 8, n. 4, pp. 253-5, PMID 9777542.
F. Roy-Péaud, MC. Pérault-Pochat; M. Paccalin; G. Le Moal; C. Landron; L. Juhel; P. Roblot; B. Becq-Giraudon, [Pigmented lesions secondary to indapamide]., in Rev Med Interne, vol. 23, n. 7, Lug 2002, p. 674, PMID 12162228.
JL. Schmutz, A. Barbaud; P. Trechot, [Indapamide-induced pemphigus foliaceus a sulfurous affair?]., in Ann Dermatol Venereol, vol. 129, n. 8-9, p. 1085, PMID 12442120.
D. Bayramgürler, C. Erçin; R. Apaydin; G. Unal, Indapamide-induced pemphigus foliaceus., in J Dermatolog Treat, vol. 12, n. 3, Set 2001, pp. 175-7, DOI:10.1080/09546630152608320, PMID 12243711.
RJ. Black, P. Murphy; TJ. Robinson; KW. Scott, Toxic epidermal necrolysis associated with indapamide., in BMJ, vol. 301, n. 6763, Dic 1990, pp. 1280-1, PMID 2271846.
J. Partanen, S. Pohjola-Sintonen; M. Mäkijärvi; M. Härmä, Toxic epidermal necrolysis due to indapamide., in Arch Dermatol, vol. 129, n. 6, Giu 1993, p. 793, PMID 8507093.
SA. Spinler, NJ. Globus; JZ. Raymond; ML. Lancefield, Indapamide-associated Stevens-Johnson syndrome., in Cutis, vol. 50, n. 3, Set 1992, pp. 200-2, PMID 1526175.
C. Sanz-Muñoz, C. Martínez-Morán; MV. Torrero-Antón; A. Miranda-Romero, [Indapamide-associated Stevens-Johnson syndrome]., in Actas Dermosifiliogr, vol. 99, n. 4, Mag 2008, pp. 321-2, PMID 18394417.
P. Butaeye, B. Hubschman; G. Derrien, [Hepatitis during indapamide therapy]., in Nouv Presse Med, vol. 8, n. 18, Apr 1979, p. 1516, PMID 471729.
L. Boissonnot, M. Boissonnot; C. Charles-Gervais; JP. Breux, [Acute myopia caused by indapamide]., in Presse Med, vol. 15, n. 17, Apr 1986, pp. 802-3, PMID 2940532.
P. Blain, M. Paques; P. Massin; A. Erginay; P. Santiago; A. Gaudric, Acute transient myopia induced by indapamide., in Am J Ophthalmol, vol. 129, n. 4, Apr 2000, pp. 538-40, PMID 10764870.
M. Végh, A. Hári-Kovács; K. Réz; B. Tapasztó; A. Szabó; A. Facskó, Indapamide-induced transient myopia with supraciliary effusion: case report., in BMC Ophthalmol, vol. 13, 2013, p. 58, DOI:10.1186/1471-2415-13-58, PMID 24138779.
J. Galipienzo García, J. García de Tena, [Serious neutropenia associated to indapamide]., in Rev Clin Esp, vol. 205, n. 9, Set 2005, pp. 466-7, PMID 16194488.
EA. Hasanova, NE. Agasiyeva, Bleeding associated with indapamide SR therapy., in Ann Pharmacother, vol. 39, n. 1, Gen 2005, pp. 199-200, DOI:10.1345/aph.1E323, PMID 15590874.

oadoi.org

NS. Mok, CK. Tong; HC. Yuen, Concomitant-acquired Long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia., in Pacing Clin Electrophysiol, vol. 31, n. 6, Giu 2008, pp. 772-5, DOI:10.1111/j.1540-8159.2008.01085.x, PMID 18507554.
KP. Letsas, IP. Alexanian; LK. Pappas; SP. Kounas; M. Efremidis; A. Sideris; F. Kardaras, QT interval prolongation and torsade de pointes associated with indapamide., in Int J Cardiol, vol. 112, n. 3, Ott 2006, pp. 373-4, DOI:10.1016/j.ijcard.2005.07.055, PMID 16260053.
A. Perciaccante, A. Fiorentini, QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al., in Int J Cardiol, vol. 122, n. 3, Nov 2007, pp. 255; author reply 256-7, DOI:10.1016/j.ijcard.2006.11.245, PMID 17368589.
N. Ohashi, S. Minemura; A. Togawa; K. Ohyama, A case of hypokalemia-induced fatal arrhythmia caused by indapamide in an anorexic elderly patient., in Clin Exp Nephrol, vol. 15, n. 5, Ott 2011, pp. 761-4, DOI:10.1007/s10157-011-0474-5, PMID 21671161.
M. Debono, R. Banerjee, Indapamide-induced hyperparathyroidism: a case report., in Eur J Clin Pharmacol, vol. 63, n. 8, Ago 2007, pp. 809-11, DOI:10.1007/s00228-007-0316-2, PMID 17549466.
D. Bayramgürler, C. Erçin; R. Apaydin; G. Unal, Indapamide-induced pemphigus foliaceus., in J Dermatolog Treat, vol. 12, n. 3, Set 2001, pp. 175-7, DOI:10.1080/09546630152608320, PMID 12243711.
M. Végh, A. Hári-Kovács; K. Réz; B. Tapasztó; A. Szabó; A. Facskó, Indapamide-induced transient myopia with supraciliary effusion: case report., in BMC Ophthalmol, vol. 13, 2013, p. 58, DOI:10.1186/1471-2415-13-58, PMID 24138779.